← All organizations

Catalent

Catalent

For profitWebsite ↗

Also known as: Catalent | CATALENT | CATALENT PHARMA

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

Last known activity

May 1, 2024

Acquired by Novo Nordisk on Feb 5, 2024

Timeline

2000s

Apr 1, 2007
Catalent— Founded

2010s

Sep 13, 2016
Pharmatek Laboratries— Acquired
Nov 28, 2016
Accucaps Industries— Acquired
Jul 3, 2018
Juniper Pharmaceuticals, Inc.— Acquired
Jan 4, 2019
naproxen— Marketing Organization
Apr 14, 2019
Paragon Bioservices— Acquired

2020s

Feb 5, 2024
Novo Nordisk— Acquired By

Drugs by trial phase (7 distinct, 10 trials)

Phase 4 (1 own, 0 via acquisition)

pancrelipase

Phase 3 (3 own, 1 via acquisition)

Phase 2 (0 own, 1 via acquisition)

lidocaine

Phase 1 (1 own, 0 via acquisition)

medi1341

Indications

Studied for

Marketed drugs (3)

Subsidiaries (4 direct, 4 total across the full acquisition tree)

Recent trials (4)

NCT06383273CollaboratorPhase 3May 1, 2024
NCT03272165CollaboratorPhase 1Oct 17, 2017
NCT02200029CollaboratorPhase 3Jun 1, 2014
NCT02009410CollaboratorPhase 4Nov 1, 2013

Details

Founded: Somerset, NJ, US Apr 1, 2007
Last known activity: May 1, 2024